跳至主要内容
临床试验/ACTRN12613000493741
ACTRN12613000493741招募中2 期

Randomized, double-blind, placebo-controlled crossover study in the pre-dialysis population assessing the benefit of synbiotics on serum uremic toxin concentrations

Princess Alexandra Hospital0 个研究点目标入组 40 人开始时间: 2013年5月2日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • *CKD stage IV: GFR stable between 10-30 ml/min/1.73m2 (for the past 3 months)
  • *Able to provide informed consent

排除标准

  • *Previous transplant or on immunosuppressants
  • *Receiving/ or have received radiation to the bowel
  • *Received prebiotic, probiotic or anti-biotic therapy within 1 month of study commencement
  • *Non-English speaking
  • *Unable/unwilling to comply with frequent follow-up
  • *Active medically diagnosed Irritable Bowel Syndrome
  • *Life expectancy limited due to pre-existing malignancy or other disease (<6 months)
  • *Likely to progress to dialysis within 6 months as determined by the treating physician
  • *Likely transplant recipient within 6 months
  • *Pregnancy
  • *Severely malnourished (Subjective Global Assessment: C)

研究者

相似试验

Investigating the effect of synbiotics on uremic... | 临床试验